BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27757951)

  • 1. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC; Baker G
    Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported symptoms in patients on antiepileptic drugs in monotherapy.
    Wieshmann UC; Tan GM; Baker G
    Acta Neurol Scand; 2011 Nov; 124(5):355-8. PubMed ID: 21973277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D; Beran RG
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
    Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
    Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
    Kowski AB; Weissinger F; Gaus V; Fidzinski P; Losch F; Holtkamp M
    Epilepsy Behav; 2016 Jan; 54():150-7. PubMed ID: 26709103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y; Altun Y; Ekmekci K; Ozkul Y
    Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
    Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R
    Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
    PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.
    Brodie MJ; Yuen AW
    Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of first antiepileptic drug.
    Kwan P; Brodie MJ
    Epilepsia; 2001 Oct; 42(10):1255-60. PubMed ID: 11737159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R; Brodie MJ
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
    Svalheim S; Luef G; Rauchenzauner M; Mørkrid L; Gjerstad L; Taubøll E
    Acta Neurol Scand Suppl; 2010; (190):30-3. PubMed ID: 20586732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.